Back
Dermata Therapeutics Vs. ZyVersa Therapeutics Industry Stock Comparison
Sell
20
DRMA
Dermata Therapeutics
Last Price:
1.11
Seasonality Move:
-57.39%
Sell
8
ZVSA
ZyVersa Therapeutics
Last Price:
1.12
Seasonality Move:
-77.19%
Sell
20
Dermata Therapeutics (DRMA)
is a Sell
Is Dermata Therapeutics a Buy, Sell or Hold?
- The current Dermata Therapeutics [DRMA] share price is $1.15. The Score for DRMA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- DRMA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
8
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy, Sell or Hold?
- The current ZyVersa Therapeutics [ZVSA] share price is $1.14. The Score for ZVSA is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- ZVSA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
DRMA Stock Price Chart
What is Dermata Therapeutics's stock price today?
-
The Dermata Therapeutics share price today is $1.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing slight selling pressure.
ZVSA Stock Price Chart
What is ZyVersa Therapeutics's stock price today?
-
The ZyVersa Therapeutics share price today is $1.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVSA is experiencing slight selling pressure.
DRMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 39.31 | Sell |
| Chaikin Money Flow: | -22154 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.17 - 1.47) | Sell |
| Bollinger Bands (100): | (1.3 - 2.18) | Sell |
ZVSA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 32.26 | Sell |
| Chaikin Money Flow: | -29814 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.26 - 2.16) | Sell |
| Bollinger Bands (100): | (1.77 - 3.65) | Sell |
DRMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Sell |
| 20-day SMA: | 1.27 | Sell |
| 50-day SMA: | 1.45 | Sell |
| 200-day SMA: | 3.39 | Sell |
| 8-day EMA: | 1.17 | Sell |
| 20-day EMA: | 1.26 | Sell |
| 50-day EMA: | 1.45 | Sell |
| 200-day EMA: | 6.23 | Sell |
ZVSA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.18 | Sell |
| 20-day SMA: | 1.59 | Sell |
| 50-day SMA: | 2 | Sell |
| 200-day SMA: | 4.46 | Sell |
| 8-day EMA: | 1.24 | Sell |
| 20-day EMA: | 1.51 | Sell |
| 50-day EMA: | 1.99 | Sell |
| 200-day EMA: | 42.17 | Sell |
Dermata Therapeutics Earnings Growth & DRMA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ZyVersa Therapeutics Earnings Growth & ZVSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $698.82 per share, and an increase next year of $11.20 per share.
Dermata Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ZyVersa Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||